Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
BGC-515 by BridGene Biosciences for Malignant Mesothelioma: Likelihood of Approval
BGC-515 is under clinical development by BridGene Biosciences and currently in Phase I for Malignant Mesothelioma. According to GlobalData, Phase...
Data Insights
BGC-515 by BridGene Biosciences for Solid Tumor: Likelihood of Approval
BGC-515 is under clinical development by BridGene Biosciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase...